跳至主要内容
临床试验/ISRCTN11565046
ISRCTN11565046进行中(未招募)Unknown

PLAtelet function in Critical Illness and liver Disease (PLACID)

Royal Berkshire NHS Foundation Trust0 个研究点目标入组 30 人开始时间: 2024年5月22日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • Current participant inclusion criteria as of 24/05/2024:
  • 1. Admitted to ICU at the Royal Berkshire Hospital
  • 2. Aged 18 years old and above
  • 3. Evidence of established liver disease, or acute liver dysfunction related to underlying illness, as determined by the clinicians caring for the patient at the time of eligibility assessment.
  • Previous participant inclusion criteria:
  • 1. Known liver disease or
  • 2. Acute liver dysfunction

排除标准

  • 1. Patients on P2Y12 inhibitors (including clopidogrel, ticagrelor and prasugrel)
  • 2. Patients on treatment-dose anticoagulation, including warfarin or novel anticoagulant drugs
  • 3. Patients under 18 years of age
  • 4. Active or recent malignancy (< 1 year) or on active treatment

研究者

相似试验